Key result
Frailty syndrome in patients with an implanted ICD was associated with higher device-related concerns compared to robust patients (mean ICDC score 36.14 vs 27.56; p=0.039).
Why the study?
Frailty syndrome may increase vulnerability to anxiety and depression, but its impact on device-related concerns following ICD implantation requires assessment.
Does frailty syndrome increase concerns about life with an implantable cardioverter defibrillator in patients with an implanted ICD?
Cross-Sectional (n=103)
Does frailty syndrome increase concerns about life with an implantable cardioverter defibrillator in patients with an implanted ICD?
Frailty syndrome is highly prevalent among patients with an ICD and is significantly associated with increased device-related concerns, highlighting the need for psychological support in this vulnerable population.
Frailty-associated ICD concerns warrant clinical attention but should not yet change practice; leaves open causal links and intervention effects.
Frailty syndrome may cause cognitive decline and increased sensitivity to stressors. This can result in an increased incidence of anxiety and depression, and thus, concerns about life with an implantable cardioverter defibrillator (ICD). The aim of the study was to assess the impact of frailty syndrome on the increase in the number of device-related concerns after the implantation of an ICD. Material and methods: The study sample was a group of 103 consecutive patients (85 M; aged 71.6 ± 8.2) with an implanted ICD. The ICD Concerns Questionnaire (ICDC) was used to analyze their concerns about life with an ICD, and the Tilburg Frailty Indicator scale (TFI) was used to diagnose frailty. Results: In the group of patients with an ICD implanted, 73% had recognized frailty (83.3% women, 74.1% men); the average point value was 6.55 ± 2.67. The total ICDC questionnaire score for the patients with an implanted cardioverter defibrillator was 34.06 ± 18.15. Patients with frailty syndrome had statistically (p = 0.039) higher scores (36.14 ± 17.08) compared to robust patients (27.56 ± 20.13). In the logistic regression analysis, the presence of frailty was strongly associated with the total questionnaire score (OR = 1.0265, p = 0.00426), the severity of the concerns (OR = 1.0417, p = 0.00451), and device-specific concerns (OR = 1.0982, p = 0.00424). Conclusion: Frailty syndrome occurs in about 80% of patients after ICD implantation. The presence of frailty syndrome was strongly associated with concerns about an implantable cardioverter defibrillator.
No takes yet. Share an insight, caveat, or question.
Młynarska et al. (2020) conducted a cross-sectional in Patients with an implanted ICD (n=103). Frailty syndrome vs. Robust patients (no frailty) was evaluated on Total ICD Concerns Questionnaire (ICDC) score (OR 1.0265, p=0.00426). Frailty syndrome in patients with an implanted ICD was associated with higher device-related concerns compared to robust patients (mean ICDC score 36.14 vs 27.56; p=0.039).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: